Works matching IS 23661070 AND DT 2024 AND VI 12 AND IP 3
Results: 16
Palbociclib in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer: A Systematic Scoping Review of Real-World Evidence from Countries Outside of Western Regions that Are Underrepresented in Clinical Trials.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 3, p. 395, doi. 10.1007/s40487-024-00295-2
- By:
- Publication type:
- Article
Patient Characteristics Associated with Time to Next Treatment in Patients with Ovarian Cancer Treated with Niraparib: The PRED1CT Real-World Study.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 3, p. 599, doi. 10.1007/s40487-024-00294-3
- By:
- Publication type:
- Article
Internal Psychometric Validation of an International Burden of Illness Survey for Idiopathic Multicentric Castleman Disease.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 3, p. 491, doi. 10.1007/s40487-024-00293-4
- By:
- Publication type:
- Article
Treatment Patterns and Resource Use After Osimertinib Discontinuation in Patients with EGFR + Metastatic NSCLC.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 3, p. 549, doi. 10.1007/s40487-024-00292-5
- By:
- Publication type:
- Article
From Triple- to Penta-Exposed Multiple Myeloma: A Real-World Study in a Medicare Population.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 3, p. 565, doi. 10.1007/s40487-024-00291-6
- By:
- Publication type:
- Article
Early Identification and Management of Patients with Rash on Apalutamide.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 3, p. 609, doi. 10.1007/s40487-024-00290-7
- By:
- Publication type:
- Article
Pharmacokinetics, Safety, Tolerability, and Immunogenicity of BP02 (Trastuzumab Biosimilar) Compared to EU- and US-Approved Trastuzumab in Healthy Adult Male Volunteers: A Phase 1, Randomized, Double-Blind Study.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 3, p. 477, doi. 10.1007/s40487-024-00289-0
- By:
- Publication type:
- Article
Disability Associated with Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation: Analysis of a Cross-Sectional US Patient Survey.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 3, p. 451, doi. 10.1007/s40487-024-00288-1
- By:
- Publication type:
- Article
Dynamic Changes in Circulating Tumor Fraction as a Predictor of Real-World Clinical Outcomes in Solid Tumor Malignancy Patients Treated with Immunotherapy.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 3, p. 509, doi. 10.1007/s40487-024-00287-2
- By:
- Publication type:
- Article
Exploring a Novel Approach to Spare Classic Chemotherapy in HER2-Low, ER-Positive Breast Cancer Based on Trastuzumab Deruxtecan Combined with Endocrine Therapy.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Cost-effectiveness of Pembrolizumab in Combination with Chemotherapy as Neoadjuvant Treatment and Continued as a Single Agent Adjuvant Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer in Hong Kong.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 3, p. 525, doi. 10.1007/s40487-024-00285-4
- By:
- Publication type:
- Article
Real-World Study of Adjuvant Biosimilar Trastuzumab-dkst for HER2-Positive Breast Cancer Treatment in a Brazilian Population.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 3, p. 437, doi. 10.1007/s40487-024-00284-5
- By:
- Publication type:
- Article
Desensitization Strategies for Donor-Specific Antibodies in HLA-Mismatched Stem Cell Transplantation Recipients: What We Know and What We Do Not Know.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 3, p. 375, doi. 10.1007/s40487-024-00283-6
- By:
- Publication type:
- Article
Long-Term Safety and Effectiveness of Rituximab Biosimilar RTXM83: A Retrospective Extension Study in Brazilian Patients with Diffuse Large B-Cell Lymphoma.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 3, p. 585, doi. 10.1007/s40487-024-00282-7
- By:
- Publication type:
- Article
Real-World First-Line Maintenance Niraparib Monotherapy Use Following Chemotherapy Plus Bevacizumab: The SW1TCH Study.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 3, p. 465, doi. 10.1007/s40487-024-00281-8
- By:
- Publication type:
- Article
Cisplatin Monotherapy as a Treatment Option for Patients with HER-2 Negative Breast Cancer Experiencing Hepatic Visceral Crisis or Impending Visceral Crisis.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 3, p. 419, doi. 10.1007/s40487-024-00280-9
- By:
- Publication type:
- Article